Population pharmacokinetics of oseltamivir and oseltamivir carboxylate in obese and Non-obese volunteers.

Population pharmacokinetics of oseltamivir and oseltamivir carboxylate in obese and Non-obese volunteers.

The aims of this study were to compare the pharmacokinetics of oseltamivir and oseltamivir carboxylate in obese and non-obese individuals and to determine the effect of obesity on the pharmacokinetic properties of oseltamivir and the active antiviral metabolite oseltamivir carboxylate.The population...

Πλήρης περιγραφή

Λεπτομέρειες βιβλιογραφικής εγγραφής
Κύριοι συγγραφείς:	Chairat, K, Jittamala, P, Hanpithakpong, W, Day, N, White, N, Pukrittayakamee, S, Tarning, J
Μορφή:	Journal article
Γλώσσα:	English
Έκδοση:	Wiley 2016

Παρόμοια τεκμήρια

Pharmacokinetics of orally administered oseltamivir in healthy obese and nonobese Thai subjects.
ανά: Jittamala, P, κ.ά.
Έκδοση: (2014)

Comparison of oseltamivir and oseltamivir carboxylate concentrations in venous plasma, venous blood, and capillary blood in healthy volunteers.
ανά: Instiaty, I, κ.ά.
Έκδοση: (2013)

Pharmacokinetics of orally administered oseltamivir in healthy obese and nonobese thai subjects
ανά: Jittamala, P, κ.ά.
Έκδοση: (2014)

Pharmacokinetics of high-dose oseltamivir in healthy volunteers.
ανά: Wattanagoon, Y, κ.ά.
Έκδοση: (2009)

Effects of dexamethasone coadministered with oseltamivir on the pharmacokinetics of oseltamivir in healthy volunteers
ανά: Jang K, κ.ά.
Έκδοση: (2017-03-01)

Development and validation of a liquid chromatographic-tandem mass spectrometric method for determination of oseltamivir and its metabolite oseltamivir carboxylate in plasma, saliva and urine.
ανά: Lindegårdh, N, κ.ά.
Έκδοση: (2007)

An open-label crossover study to evaluate potential pharmacokinetic interactions between oral oseltamivir and intravenous zanamivir in healthy Thai adults.
ανά: Pukrittayakamee, S, κ.ά.
Έκδοση: (2011)

An open-label crossover study to evaluate potential pharmacokinetic interactions between oral oseltamivir and intravenous zanamivir in healthy thai adults
ανά: Pukrittayakamee, S, κ.ά.
Έκδοση: (2011)

Chemical analysis and transplacental transfer of oseltamivir and oseltamivir carboxylic acid in pregnant rats.
ανά: Chia-Chun Lin, κ.ά.
Έκδοση: (2012-01-01)

Combination therapy with amantadine, oseltamivir and ribavirin for influenza A infection: safety and pharmacokinetics.
ανά: Seo, S, κ.ά.
Έκδοση: (2013)

Plasma concentrations of oseltamivir and oseltamivir carboxylate in critically ill children on extracorporeal membrane oxygenation support.
ανά: Enno D Wildschut, κ.ά.
Έκδοση: (2010-01-01)

Enantiospecific pharmacokinetics and drug-drug interactions of primaquine and blood-stage antimalarial drugs
ανά: Chairat, K, κ.ά.
Έκδοση: (2018)

Population pharmacokinetics and electrocardiographic effects of dihydroartemisinin-piperaquine in healthy volunteers
ανά: Chotsiri, P, κ.ά.
Έκδοση: (2017)

A physiologically-based pharmacokinetic model of oseltamivir phosphate and its carboxylate metabolite for rats and humans
ανά: Guanghua Gao, κ.ά.
Έκδοση: (2019-02-01)

Oseltamivir Population Pharmacokinetics in the Ferret: Model Application for Pharmacokinetic/Pharmacodynamic Study Design.
ανά: Micaela B Reddy, κ.ά.
Έκδοση: (2015-01-01)

Efficacy of oseltamivir treatment in influenza virus-infected obese mice
ανά: Rebekah Honce, κ.ά.
Έκδοση: (2023-08-01)

Importance of collection tube during clinical studies of oseltamivir.
ανά: Lindegardh, N, κ.ά.
Έκδοση: (2007)

Ode to Oseltamivir and Amantadine?
ανά: JM Conly, κ.ά.
Έκδοση: (2006-01-01)

Oseltamivir and inhaled zanamivir as influenza prophylaxis in Thai health workers: a randomized, double-blind, placebo-controlled safety trial over 16 weeks.
ανά: Anekthananon, T, κ.ά.
Έκδοση: (2013)

Combination therapy of nitazoxanide with oseltamivir compared with oseltamivir in hospitalized patients with seasonal influenza
ανά: Parvaiz A Koul, κ.ά.
Έκδοση: (2024-01-01)

Rapid degradation of oseltamivir phosphate in clinical samples by plasma esterases.
ανά: Lindegardh, N, κ.ά.
Έκδοση: (2006)

Impact of Oseltamivir and Diabetes Development
ανά: Bor-Show Tzang, κ.ά.
Έκδοση: (2025-01-01)

Impact of oseltamivir on the risk of cancer
ανά: Pei-Hua Chuang, κ.ά.
Έκδοση: (2024-02-01)

Rapid Emergence of Oseltamivir Resistance
ανά: Cheng Len Sy, κ.ά.
Έκδοση: (2010-04-01)

Assay to Detect Oseltamivir Resistance
ανά: Kamol Suwannakarn, κ.ά.
Έκδοση: (2006-12-01)

Oseltamivir in pregnancy and birth outcomes
ανά: Vera Ehrenstein, κ.ά.
Έκδοση: (2018-10-01)

Impact of Oseltamivir Treatment on Influenza A and B Virus Dynamics in Human Volunteers
ανά: Kyla L. Hooker, κ.ά.
Έκδοση: (2021-03-01)

Pharmacokinetic interactions between primaquine and chloroquine.
ανά: Pukrittayakamee, S, κ.ά.
Έκδοση: (2014)

Oseltamivir and inhaled zanamivir as influenza prophylaxis in thai health workers: A randomized, double-blind, placebo-controlled safety trial over 16 weeks. [J Antimicrob Chemother 68, (2013) 697-707]
ανά: Anekthananon, T, κ.ά.
Έκδοση: (2013)

Strategies for the Use of Oseltamivir and Zanamivir during Pandemic Outbreaks
ανά: Elsa Hansen, κ.ά.
Έκδοση: (2010-01-01)

OSELTAMIVIR MEDICATION IN THE PEDIATRIC PRACTICE: THE REVIEW
ανά: A.B. Ivanyuk, κ.ά.
Έκδοση: (2008-01-01)

OSELTAMIVIR MEDICATION IN THE PEDIATRIC PRACTICE: THE REVIEW
ανά: A.B. Ivanyuk, κ.ά.
Έκδοση: (2008-01-01)

Oseltamivir and G6PD deficiency
ανά: Şinasi Özsoylu
Έκδοση: (2010-06-01)

Oseltamivir and G6PD deficiency
ανά: Şinasi Özsoylu
Έκδοση: (2010-06-01)

Oseltamivir Enhances Hippocampal Network Synchronization
ανά: Atsushi Usami, κ.ά.
Έκδοση: (2008-01-01)

Oseltamivir for the treatment of influenza in children and adolescents
ανά: Alfredo Tagarro, κ.ά.
Έκδοση: (2019-05-01)

Wonderful drug for walking pneumonia: oseltamivir
ανά: Faheem Arshad, κ.ά.
Έκδοση: (2014-01-01)

Inhibition of Influenza Virus Replication by Oseltamivir Derivatives
ανά: Renee W. Y. Chan, κ.ά.
Έκδοση: (2022-02-01)

Safety and pharmacokinetic properties of a new formulation of parenteral artesunate in healthy Thai volunteers
ανά: Tarning, J, κ.ά.
Έκδοση: (2024)

A randomized, crossover study to evaluate the pharmacokinetics of amantadine and oseltamivir administered alone and in combination.
ανά: Dennis Morrison, κ.ά.
Έκδοση: (2007-12-01)